ArticleCancer chemotherapy and pharmacology2020

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).

Emily Greengard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.